FR3308M - Nouvelles pipérazines utilisables en thérapeutique, notamment comme agents anti-inflammatoires. - Google Patents

Nouvelles pipérazines utilisables en thérapeutique, notamment comme agents anti-inflammatoires.

Info

Publication number
FR3308M
FR3308M FR970793A FR970793A FR3308M FR 3308 M FR3308 M FR 3308M FR 970793 A FR970793 A FR 970793A FR 970793 A FR970793 A FR 970793A FR 3308 M FR3308 M FR 3308M
Authority
FR
France
Prior art keywords
therapy
inflammatory agents
piperazines
new
new piperazines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR970793A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR961022A external-priority patent/FR1404442A/fr
Application filed by Ciba Geigy AG, Ciba AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of FR3308M publication Critical patent/FR3308M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/092—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR970793A 1963-01-23 1964-04-14 Nouvelles pipérazines utilisables en thérapeutique, notamment comme agents anti-inflammatoires. Active FR3308M (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25327063A 1963-01-23 1963-01-23
US31534363A 1963-10-10 1963-10-10
FR961022A FR1404442A (fr) 1963-01-23 1964-01-21 Procédé de préparation de composés pipéraziniques, entre autres de la 1-(2-éthoxy-2-phényléthyl)-4-(2-méthoxy-phényl)-pipérazine

Publications (1)

Publication Number Publication Date
FR3308M true FR3308M (fr) 1965-05-10

Family

ID=26943082

Family Applications (2)

Application Number Title Priority Date Filing Date
FR970793A Active FR3308M (fr) 1963-01-23 1964-04-14 Nouvelles pipérazines utilisables en thérapeutique, notamment comme agents anti-inflammatoires.
FR970794A Active FR3309M (fr) 1963-01-23 1964-04-14 Nouvelle pipérazine utilisable en thérapeutique, notamment comme antiphlogistique.

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR970794A Active FR3309M (fr) 1963-01-23 1964-04-14 Nouvelle pipérazine utilisable en thérapeutique, notamment comme antiphlogistique.

Country Status (7)

Country Link
AT (10) AT247343B (fr)
BE (2) BE642844A (fr)
CH (6) CH446346A (fr)
ES (2) ES295632A1 (fr)
FR (2) FR3308M (fr)
GB (2) GB1047044A (fr)
NL (2) NL6400466A (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1307563A (zh) * 1998-06-30 2001-08-08 泽里新药工业株式会社 N－苯基－n′－苯丙基哌嗪衍生物及其制备方法
USD1009638S1 (en) * 2019-06-07 2024-01-02 Seiko Epson Corporation Packaging container
USD979418S1 (en) * 2019-06-28 2023-02-28 Seiko Epson Corporation Packaging container

Also Published As

Publication number Publication date
ES295632A1 (es) 1964-07-16
AT247346B (de) 1966-06-10
CH446345A (de) 1967-11-15
AT247349B (de) 1966-06-10
CH446349A (de) 1967-11-15
CH446348A (de) 1967-11-15
NL6400466A (fr) 1964-07-24
CH446347A (de) 1967-11-15
AT247347B (de) 1966-06-10
GB1047044A (en) 1966-11-02
AT247336B (de) 1966-06-10
AT247337B (de) 1966-06-10
AT247350B (de) 1966-06-10
GB1048903A (en) 1966-11-23
BE642845A (fr) 1964-07-22
AT247342B (de) 1966-06-10
NL6400467A (fr) 1964-07-24
AT247348B (de) 1966-06-10
CH446346A (de) 1967-11-15
CH449629A (de) 1968-01-15
AT247343B (de) 1966-06-10
BE642844A (fr) 1964-07-22
AT247351B (de) 1966-06-10
ES295631A1 (es) 1964-07-16
FR3309M (fr) 1965-05-10

Similar Documents

Publication Publication Date Title
FR3290M (fr) Nouvelles amines utilisables en thérapeutique, notamment comme inhibiteurs de la mono-aminoxydase.
NL144526B (nl) Rasp.
FR3071M (fr) Nouvelles protéases pancréatiques, utilisables notamment en gastro-entérologie.
FR3846M (fr) Nouvelles 4-amino-pipéridines.
FR2770M (fr) Nouvelles dihalogéno-amino-benzylamines.
FR3380M (fr) Nouvelles préparations anthelmintiques, utilisables en thérapeutique.
FR3644M (fr) Nouvelles quinazolines utilisables en thérapeutique, notamment comme analgésiques.
OA00772A (fr) Composition dermatologie.
FR3773M (fr) Nouvelles 5h-dihydrothiopyrano-[4,3-d]-pyrimidines.
FR3734M (fr) Nouvelle pipérazine utilisable en thérapeutique, notamment comme agent hypotenseur.
FR3308M (fr) Nouvelles pipérazines utilisables en thérapeutique, notamment comme agents anti-inflammatoires.
FR3770M (fr) Nouvelles lactones utiles comme agents hypocholestérémiques.
BE647221A (fr) 3,5-dialkyl-4-hydroxy-plenylacetic acid derivatives.
FR3689M (fr) Compositions émollientes.
FR3259M (fr) Nouvelles compositions hypoglycémiantes.
FR2692M (fr) Nouveaux a-nor-b-homo-stéroides utilisables en thérapeutique, notamment comme agents anti-inflammatoires.
FR3864M (fr) Nouvelles pipérazines utilisables en thérapeutique, notamment comme agents hypotenseurs.
FR3110M (fr) Nouvelles benzamides.
FR3534M (fr) Nouvelle isoquinoléine utilisable en thérapeutique, notamment comme agent antitussif.
FR3046M (fr) Nouvelles phényléthanolamines.
FR3805M (fr) Nouvelle &delta<4>-7α-méthyl-17β-hydroxy-19-nor-androstene-3-one utilisable en thérapie.
FR3325M (fr) Nouvelles 2-alcoyl-4-pyridine-aldéhyde-thiosemicarbazones.
BE642025A (fr) Nouvelles indolylalcoylguanidines.
FR2998M (fr) Nouvelles guanidines utilisables en thérapeutique, notamment comme hypoglycémiants.
FR2365M (fr) Nouvelles guanidines utilisables en thérapeutique, notamment comme hypoglycémiants.